News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Health-related Consequences of and Treatment Strategies for Dyslipidemia

Therapeutic Dose Assessment of Patient Switching from Atorvastatin to Simvastatin

ByGregory Hess, MD, MBA,Kafi N. Sanders, MPH,Jerrold Hill, PhD,Larry Z. Liu, MD, PhD

June 1st 2007

Racial Differences in Switching, Augmentation, and Titration of Lipid-lowering Agents by Medicare/Medicaid Dual-eligible Patients

ByTami L. Mark, PhD, MBA,Kirsten J. Axelsen, MS,Lisa Mucha, PhD,Yelena Sadkova, MS

June 1st 2007

Epidemiology of Dyslipidemia and Economic Burden on the Healthcare System

ByDean G. Smith, PhD

June 1st 2007

Trending on AJMC

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms

Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.